Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain.

Autor: Ortiz Zuñiga, Angel Michael^1,2 (AUTHOR) a.ortiz@vhebron.net, Simó, Rafael^1,2 (AUTHOR) cristina.hernandez@vhir.org, Rodriguez-Gómez, Octavio³ (AUTHOR) orodriguez@fundacioace.org, Hernández, Cristina^1,2 (AUTHOR), Rodrigo, Adrian⁴ (AUTHOR) arodrigo@gmv.com, Jamilis, Laura⁴ (AUTHOR) ljamilis@gmv.com, Campo, Laura⁵ (AUTHOR) campo_laura@lilly.com, Alegret, Montserrat³ (AUTHOR) malegret@fundacioace.com, Boada, Merce^3,6 (AUTHOR) rafael.simo@vhir.org, Ciudin, Andreea^1,2 (AUTHOR) rafael.simo@vhir.org

Publikováno v: Journal of Clinical Medicine. Sep2020, Vol. 9 Issue 9, p2726. 1p.